TickerFacts.

CEL SCI Corp (CVM): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2013-12-27; 1-for-25, first reflected in a filing dated 2017-08-09; 1-for-30, first reflected in a filing dated 2025-08-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$6.27
Year ended 2025-09-30
2009-09-30: -$0.312010-09-30: -$0.062011-09-30: -$1.492012-09-30: -$0.782013-09-30: -$0.662014-09-30: -$12.212015-09-30: -$10.512016-09-30: -$2.372017-09-30: -$1.912018-09-30: -$1.872019-09-30: -$0.712020-09-30: -$0.822021-09-30: -$0.902022-09-30: -$0.872023-09-30: -$0.732024-09-30: -$15.312025-09-30: -$6.27-$6.27
2009-09-30 EPS (Diluted) (USD per share) 2025-09-30

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Diluted)Change YoYSource filing
2025-09-30-$6.27n/m2025-12-29, From 2024-10-01
2024-09-30-$15.31n/c2025-12-29, From 2023-10-01
2023-09-30-$0.73n/m2025-01-13, From 2022-10-01
2022-09-30-$0.87n/m2022-12-27, From 2021-10-01
2021-09-30-$0.90n/c2022-12-27, From 2020-10-01
2020-09-30-$0.82n/m2021-12-21, From 2019-10-01
2019-09-30-$0.71n/m2019-12-23, From 2018-10-01
2018-09-30-$1.87n/m2019-12-23, From 2017-10-01
2017-09-30-$1.91n/m2018-12-19, From 2016-10-01
2016-09-30-$2.37n/m2017-12-29, From 2015-10-01
2015-09-30-$10.51n/m2017-12-11, From 2014-10-01
2014-09-30-$12.21n/c2017-12-11, From 2013-10-01
2013-09-30-$0.66n/m2015-12-11, From 2012-10-01
2012-09-30-$0.78n/m2014-12-23, From 2011-10-01
2011-09-30-$1.49n/c2013-12-27, From 2010-10-01
2010-09-30-$0.06n/m2012-12-14, From 2009-10-01
2009-09-30-$0.31n/a2011-12-23, From 2008-10-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
CEL SCI Corp (CVM)2025-09-30-$6.27n/m
Champions Oncology, Inc. (CSBR)2026-04-30-$0.08n/m
Pluri Inc. (PLUR)2026-06-30-$2.44n/m
IN8BIO, Inc. (INAB)2025-12-31-$4.44n/m
Inmune Bio, Inc. (INMB)2025-12-31-$1.86n/m
Jasper Therapeutics, Inc. (JSPR)2025-12-31-$3.95n/m
Atara Biotherapeutics, Inc. (ATRA)2025-12-31$2.57n/m
Curis Inc (CRIS)2025-12-31-$0.58n/m
Outlook Therapeutics, Inc. (OTLK)2025-09-30-$1.79n/m

Compare CVM, CSBR, PLUR, INAB side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗